[{"Assets_0_FY_USD":385714000.0,"CommonStockSharesOutstanding_0_FY_shares":325850013.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-94703000.0,"NetIncomeLoss_4_FY_USD":-116445000.0,"NetIncomeLoss_1_FY_USD":-33670000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":297237000.0,"StockholdersEquity_0_FY_USD":152330000.0,"EarningsPerShareBasic_4_FY_USD":-0.39,"EarningsPerShareBasic_1_FY_USD":-0.11,"Ticker":"AMRN","CIK":"897448","name":"AMARIN CORP PLCUK","OfficialName":"Amarin Corporation plc","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265593617.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190227"}]